Ads for compounded semaglutide and tirzepatide are everywhere, usually leading with price. This page is the part the ads leave out: who actually verifies each kind of product, what changed when the shortages ended, and what to check before you buy anything.
Verified Aug 12, 2026Quick answer: a compounded GLP-1 is not a generic and not FDA-approved — FDA doesn't review it for safety, effectiveness, or quality before it's sold. It's a different product than the brands, legal only in narrow circumstances since the shortages ended, and its price advantage has narrowed now that the pen is published at $199/mo and savings cards floor at $25.
Same active ingredient names — different products, different oversight.
FDA-approved
The brand products — Wegovy, Ozempic, Zepbound, Mounjaro — made by Novo Nordisk and Eli Lilly.
Compounded
A pharmacy-made version of the active ingredient (semaglutide or tirzepatide), sometimes with additives or in forms the brands don't come in.
FDA-approved
FDA reviews safety, effectiveness, and manufacturing quality before approval, and inspects manufacturing on an ongoing basis.
Compounded
No one at the federal level: FDA does not review compounded drugs for safety, effectiveness, or quality before they're marketed. Oversight is mostly state pharmacy boards.
FDA-approved
Always — it's the standard, approved product.
Compounded
In narrow circumstances (like a patient-specific clinical need). The broad allowance tied to the drug shortages ended in 2025.
FDA-approved
Published, verifiable prices: pen from $199/mo at two telehealth providers, $349–$399 direct from the manufacturer, $25/mo card floor with covered commercial insurance.
Compounded
Often advertised in the $97–$349/mo range all-in — a gap that has narrowed sharply now that manufacturers sell direct at published prices.
The legal basis for mass-market compounded GLP-1s was the drug shortages — and the shortages ended.
FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025.
Enforcement discretion for compounders wound down on a published schedule — by May 2025, mass-producing compounded versions of these drugs was no longer permitted.
Programs still selling compounded GLP-1s rely on narrower exceptions, like patient-specific formulations. That's exactly why the checklist below matters more, not less, than it did during the shortage era.
Five checks, in order. This is the same standard we'd hold any seller to — published so you can apply it yourself.
A legitimate program tells you which pharmacy compounds and dispenses your medication, and that pharmacy holds a state license you can look up. "Our pharmacy partners" with no names is a stop sign.
Compounded versions are not generics. A seller marketing "generic Ozempic" or "generic Zepbound" is describing something that doesn't exist — what's in the vial is compounded at best, counterfeit at worst.
Active ingredients sold as "research chemicals" or peptides "not for human use" sit outside the drug-safety system entirely — there's no pharmacy, no prescriber, and no license to check.
Which active ingredient, what concentration, what additives, injection or oral form — in writing, before you pay. Compounded doses don't map one-to-one to brand pen strengths, which matters if you ever switch.
The strongest reason people chose compounded was price — and that math has changed. Before assuming brand is out of reach, check the published prices: the pen from $199/mo, manufacturer-direct from $299–$449, and $25/mo with a covered commercial plan.
Where we stand: this site lists and compares FDA-approved pathways only — we write about the compounded category so you know exactly what you'd be buying, but we don't list or link to sellers of non-FDA-approved versions, and no payment changes that. The full policy is on How we verify.
This page summarizes FDA policy statements and consumer guidance current as of the verified date above; it is not medical or legal advice. Whether any medication — branded or compounded — fits your situation is a decision for you and a licensed prescriber.